Yerba mate (Ilex paraguariensis) improves microcirculation of volunteers with high blood viscosity: A randomized, double-blind, placebo-controlled trial

Experimental Gerontology

Volumn 62, Issue , 2015, Pages 14-22

  Yu, Shaohong ^a   Yue, Shou Wei ^a   Liu, Zhaochun ^b   Zhang, Tiefeng ^c   Xiang, Nan ^b   Fu, Hui ^d  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Jinan Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^d SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Blood viscosity; Hemorheology; Nailfold microcirculation; Yerba mate (Ilex paraguariensis)

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CHOLESTEROL; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; THROMBOXANE B2; TRIACYLGLYCEROL; LIPID; PLANT EXTRACT;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD RHEOLOGY; BLOOD VISCOSITY; CAPILLARY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOLOGICAL PARAMETERS; HERBAL TEA; HUMAN; ILEX PARAGUARIENSIS; IN VIVO STUDY; MALE; MICROCIRCULATION; NAILFOLD MICROCIRCULATION; NORMAL HUMAN; PLASMA VISCOSITY; PROSTAGLANDIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VOLUNTEER; ANATOMY AND HISTOLOGY; BLOOD; DRUG EFFECTS; MIDDLE AGED; NAIL; PHYTOTHERAPY; PROCEDURES; VASCULARIZATION; YOUNG ADULT;

ANIMALIA; CROTON OVALIFOLIUS; ILEX PARAGUARIENSIS;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; BLOOD VISCOSITY; CAPILLARIES; DOUBLE-BLIND METHOD; FEMALE; HEMORHEOLOGY; HUMANS; ILEX PARAGUARIENSIS; LIPIDS; MALE; MICROCIRCULATION; MIDDLE AGED; NAILS; PHYTOTHERAPY; PLANT EXTRACTS; THROMBOXANE B2; YOUNG ADULT;

EID: 84920601978     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.12.016     Document Type: Article

References (58)

1. Abularrage C.J., Sidawy A.N., Aidinian G., Singh N., Weiswasser J.M., Arora S. Evaluation of the microcirculation in vascular disease. J. Vasc. Surg. 2005, 42(3):574-581.
2. Ajmani R.S. Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function. Neurobiol. Aging 2000, 21(2):257-269.
3. Antonios T.F., Raghuraman R.P., D'Souza R., Nathan P., Wang D. Capillary remodeling in infants born to hypertensive pregnancy: pilot study. Am. J. Hypertens. 2012, 25(8):848-853.
4. Arçari D.P., Bartchewsky W., dos Santos T.W., et al. Antiobesity effects of yerba mate extract (Ilex paraguariensis) in high-fat diet-induced obese mice. Obesity 2009, 17:2127-2133.
5. Bagot C.N., Arya R. Virchow's triad, a question of attribution. Br. J. Haematol. 2008, 143:180-190.
6. Bastos Deborah H.M., Matsumoto Ruth L.T., Mendonça Simone, Nunes Valéria S. Effects of Mate tea (Ilex paraguariensis) ingestion on mRNA expression of antioxidant enzymes, lipid peroxidation, and total antioxidant status in healthy young women. J. Agric. Food Chem. 2009, 57(5):1775-1780.
7. Bernáth I., Bernát I., Pongrácz E., Köves P., Szakács Z., Horváth A. Effects of blood hyperviscosity on functional integrity in the brain stem: a brain stem evoked auditory potential study. Clin. Hemorheol. Microcirc. 2004, 31(2):123-128.
8. Bixby M., Spieler L., Menini T., Gugliucci A. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress, a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci. 2005, 77:345-358.
9. Bixby M., Spieler L., Menini T. Ilex paraguariensis extracts are potent inhibitors of nitrosative stress: a comparative study with green tea and wines using a protein nitration model and mammalian cell cytotoxicity. Life Sci. 2005, 77:345-358.
10. Bravo L., Goya L., Lecumberri E. LC/MS characterization of phenolic constituents of Mate and its antioxidant activity compared to commonly consumed beverages. Food Res. Int. 2007, 40:393-405.
11. Brown M.M., Marshall J. Effect of plasma exchange on blood viscosity and cerebral blood flow. Br. Med. J. 1982, 284:1733-1736.
12. Burris K.P., Davidson P.M., Stewart C.N. Antimicrobial activity of Yerba Mate (ilex paraguariensis) aqueous extracts against Escherichia coli O157, h7 and Staphylococcus aureus. J. Food Sci. 2011, 76:456-462.
13. Cecchi Emanuele, Marcucci Rossella, Poli Daniela, Antonucci Emilia, Abbate Rosanna Hyperviscosity as a possible risk factor for cerebral ischemic complications in atrial fibrillation patients. Am. J. Cardiol. 2006, 97:1745-1748.
14. Ciuffetti G. Prognostic impact of low-shear whole blood viscosity in hypertensive men. Eur. J. Clin. Investig. 2005, 35(2):93-98.
15. Coull B.M., Beamer N., de Garmo P., Sexton G., Nordt F., Knox R., Seaman G.V. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke 1991, 22(2):162-168.
16. Coull B.M., Beamer N., de Garmo P., Sexton G., Nordt F., Knox R., Seaman G.V. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke 1991, 22:162-168.
17. DeFilippis A.P., Law K., Curtin S., Eckman J.R. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease. Cardiol. Rev. 2007, 15(1):31-34.
18. Den Uil C.A., Lagrand W.K., van der Ent M., Jewbali L.S., Cheng J.M., Spronk P.E., Simoons M.L. Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur. Heart J. 2010, 31(24):3032-3039.
19. Ellahham S. Role of antiplatelet agents in the primary and secondary prevention of atherothrombotic events in high risk-patients. South. Med. J. 2008, 101:273-283.
20. Fedele F., Mancone M., Chilian W.M., Severino P., Canali E., Logan S., De Marchis M.L., Volterrani M., Palmirotta R., Guadagni F. Role of Genetic Polymorphisms of Ion Channels in the Pathophysiology of Coronary Microvascular Dysfunction and Ischemic Heart Disease 2013, 108(6):387.
21. Fernandes E.S., de Oliveira Machado M., Becker A.M. Yerba mate (Ilex paraguariensis) enhances the gene modulation and activity of paraoxonase-2: in vitro and in vivo studies. Nutrition 2012, 28(11-12):1157-1164.
22. Forconi S., Gori T. The evolution of the meaning of blood hyperviscosity in cardiovascular physiopathology: should we reinterpret Poiseuille?. Clin. Hemorheol. Microcirc. 2009, 42(1):1-6.
23. Fu X., Wang M., Li S., Li Y. The effect of bamboo leaves extract on hemorheology of normal rats. J. Chin. Med. Mater. 2005, 28(2):130-132.
24. Gao H., Liu Z., Qu X. Effects of Yerba Mate tea (Ilex paraguariensis) on vascular endothelial function and liver lipoprotein receptor gene expression in hyperlipidemic rats. Fitoterapia 2013, 84:264-272.
25. Gao H., Liu Z., Wan W., Qu X., Chen M. Aqueous extract of Yerba Mate tea lowers atherosclerotic risk factors in a rat hyperlipidemia model. Phytother. Res. 2013, 27(8):1225-1231.
26. Gao Hongli, Long Yuezhou, Jiang Xinquan, Liu Zhaochun, Wang Decai, Zhao Ying, Li Dawei, Sun Bao-liang Beneficial effects of Yerba Mate tea (Ilex paraguariensis) on hyperlipidemia in high-fat-fed hamsters. Exp. Gerontol. 2013, 48:572-5781.
27. Gorgen M., Turatti K., Medeiros A.R. Aqueous extract of Ilex paraguariensis decreases nucleotide hydrolysis in rat blood serum. J. Ethnopharmacol. 2005, 97:73-77.
28. Gosmann G., Barlette A.G., Dhamer T. Phenolic compounds from mate (Ilex paraguariensis) inhibit adipogenesis in 3T3-L1 preadipocytes. Plant Foods Hum. Nutr. 2012, 67(2):156-161.
29. Harry A.J., Strijber B., Jos L.M. The microcirculation and hypertension. Hypertension 1992, 10:147-148.
30. Higgins C. Recurrence of venous thromboembolism. Biomed. Sci. 2006, 50:865-867.
31. Hussein G.M., Matsuda H., Nakamura S., Akiyama T., Tamura K., Yoshikawa M. Protective and ameliorative effects of mate (Ilex paraguariensis) on metabolic syndrome in TSOD mice. Phytomedicine 2011, 19(1):88-97.
32. Ikram M.K., Witteman J.C., Vingerling J.R., Breteler M.M., Hofman A., de Jong P.T. Retinal vessel diameters and risk of hypertension: the Rotterdam study. Hypertension 2006, 47(2):189-194.
33. Joutel Anne, Monet-Leprêtre Marie, Gosele Claudia, Baron-Menguy Céline, Hammes Annette Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. J. Clin. Investig. 2010, 120(2):433-445.
34. Kang Y.R., Lee H.Y., Kim J.H., Moon D.I., Seo M.Y., Park S.H. Anti-obesity and anti-diabetic effects of Yerba Mate (Ilex paraguariensis) in C57BL/6J mice fed a high-fat diet. Lab. Anim. Res. 2012, 28(1):23-29. (2012).
35. Kensey K.R., Cho Y.I., Chang M. Effects of whole blood viscosity on atherogenesis. J. Invasive Cardiol. 1997, 9(1):17-24.
36. Koenig Wolfgang, Sund Malte, Filipiak Birgit, Döring Angela, Löwel Hannelore, Ernst Edzard Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler. Thromb. Vasc. Biol. 1998, 18(5):768-772.
37. Koudstaal S., Jansen Of Lorkeers SJ, van Slochteren F.J., van der Spoel T.I., van de Hoef T.P., Sluijter J.P., Siebes M., Doevendans P.A., Piek J.J., Chamuleau S.A. Assessment of coronary microvascular resistance in the chronic infarcted pig heart 2013, 17(9):1128-1135.
38. Lanzetti M., Bezerra F.S., Romana-Souza B. Mate tea reduced acute lung inflammation in mice exposed to cigarette smoke. Nutrition 2008, 24(4):375-381.
39. Larcan A., Stoltz J.F. Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic deductions. Ann. Med. Interne 1983, 134(5):395-410.
40. Lockhart C.J., Hamilton P.K., Quinn C.E., McVeigh G.E. End-organ dysfunction and cardiovascular outcomes: the role of the, microcirculation 2009, 116(3):175-190.
41. Maeda Nobuji, Seike Masahiko, Kume Shingo, Takaku Takeshi, Shiga Takeshi Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule. Biochim. Biophys. Acta 1987, 904:81-91.
42. Martínez M., Vayá A., Martínez M., Vayá A., Server R., Gilsanz A., Aznar J. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane. Clin. Hemorheol. Microcirc. 1998, 18:253-258.
43. Martínez M., Vayá A., Server R., Gilsanz A., Aznar J. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane. Clin. Hemorheol. Microcirc. 1998, 18:253-258.
44. Moh J.H., Cho Y.I., Cho D.J., Kim D., Banerjee R.K. Influence of non-Newtonian viscosity of blood on microvascular impairment. Clin. Hemorheol. Microcirc. 2014, 28:285-286.
45. Mohler E.R. 3rd Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?. Catheter. Cardiovasc. Interv. 2009, 74:S1-S6.
46. Morais E.C., Stefanuto A., Klein G.A. Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL cholesterol reduction in individuals on statin therapy. J. Agric. Food Chem. 2009, 57:8316-8324.
47. Mosimann A.L., Wilhelm-Filho D., da Silva E.L. Aqueous extract of Ilex paraguariensis attenuates the progression of atherosclerosis in cholesterol-fed rabbits. Biofactors 2006, 26:59-70.
48. Pais E., Alexy T., Holsworth R.E., Meiselman H.J. Effects of nattokinase, a pro-fibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity. Clin. Hemorheol. Microcirc. 2006, 35(1-2):139-142.
49. Pang J., Choi Y., Park T. Ilex paraguariensis extract ameliorates obesity induced by hyperlipidemic diet, potential role of AMPK in the visceral adipose tissue. Arch. Biochem. Biophys. 2008, 476:178-185.
50. Puangpraphant S., Berhow M.A., Vermillion K. Dicaffeoylquinic acids in Yerba mate (Ilex paraguariensis St. Hilaire) inhibit NF-κB nucleus translocation in macrophages and induce apoptosis by activating caspases-8 and -3 in human colon cancer cells. Mol. Nutr. Food Res. 2011, 55(10):1509-1522.
51. Ranilla L.G., Kwon Y.I., Apostolidis E., Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 2010, 101(12):4676-4689.
52. Reaume K.T., Regal R.E., Dorsch M.P. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Ann. Pharmacother. 2008, 42:550-557.
53. Rizzoni D., Porteri E., Boari G.E., De Ciuceis C., Sleiman I., Muiesan M.L., Castellano M., Miclini M., Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 2003, 108(18):2230-2235.
54. Schmidt J.A., Caspary L., von Bierbrauer A., Ehrly A.M., Jünger M., Jung F., Lawall H. Standardization of nailfold capillary microscopy in routine diagnosis. VASA Zeitschrift fur Gefasskrankheiten 1997, 26(1):5-10.
55. Smyth E.M., Fitzegerald G.A. Prostaglandin mediator. Handbook of Cell Signaling 2003, 265-273. Academic Press, San Diego. R.D. Bradshaw (Ed.).
56. Smyth E.M., Burne A., Fitzgerald G.A. Lipid-derived autacoids: eicosanoids and platelet-activating factor. Handbook of the Pharmacological Basis of Therapeutics 2006, 653-670. McGraw-Hill, New York. Goodman and Gilman's (Ed.).
57. Uba Nwose Ezekiel Cardiovascular risk assessment and support techniques: whole blood viscosity assessment issues I: extrapolation chart and reference values. N. Am. J. Med. Sci. 2010, 2:165-169. PhD, CSci, FIBMS, MAIMS.
58. Xue W.L., Li X.S., Zhang J., Liu Y.H., Wang Z.L., Zhang R.J. Effect of Trigonella foenum extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac. J. Clin. Nutr. 2007, 16:422-426.